NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 2 hours 32 min ago

NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trials Not Allowed)

Thu, 2017-12-07 12:56
Funding Opportunity RFA-EY-17-003 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to stimulate development of translation-enabling models for evaluating survival and integration of regenerated photoreceptors (PRCs) and retinal ganglion cells (RGCs) in model systems that are closer to human visual anatomy, function and/or disease than current models. The development of these models, tools, devices, novel therapies and/or other resources is expected to provide a resource to vision researchers developing cell-replacement therapies for visual system diseases and disorders. This FOA seeks to develop models that emulate critical aspects of a human blinding disease that might be amenable to regenerative therapy. The model system might involve specific defects generated by transgenic gene insertion and/or deletion, gene editing, chemical/physical means, and/or other approaches to emulate characteristics of human disease or create defects amenable to cell-replacement therapy. Model systems using non-human primates or other cone-dominant species that are more representative of the anatomy and physiology of the human retina are highly encouraged. Other biological models are acceptable provided they meet the overall objectives of the FOA. An important aspect of this FOA is that the research team is expected to treat the loss of vision associated with the experimental model using an approach that involves regenerating PRCs and/or RGCs and their connections. The choice of cells for therapy might include adult stem cells, precursors, stem cell derived progenitor cells, or conversion of intrinsic cells such as glia. It is expected that quantitative measures will be used to evaluate survival and integration of the regenerated cells using electrophysiology, functional imaging, behavioral measures or any other appropriate technology that would demonstrate circuit integration and restoration of visual function.

Prevention and Treatment Research to Address HIV/AIDS Disparities in Women in the US (R01-Accepting applications that either propose or do not propose clinical trial(s))

Thu, 2017-12-07 11:08
Funding Opportunity RFA-MD-18-004 from the NIH Guide for Grants and Contracts. This initiative will support health services, intervention, and implementation research to understand and reduce racial/ethnic, geographic, and socioeconomic HIV disparities in US women. Projects may address HIV prevention, screening and diagnosis, and/or treatment. Projects may involve primary data collection and/or secondary analysis of existing data.

Detecting and Preventing Suicide Behavior, Ideation and Self-Harm in Youth in Contact with the Juvenile Justice System (R01- Clinical Trial Required)

Thu, 2017-12-07 11:05
Funding Opportunity PAR-18-479 from the NIH Guide for Grants and Contracts. This initiative supports research to test the effectiveness of combined strategies to both detect and intervene to reduce the risk of suicide behavior, suicide ideation, and non-suicidal self-harm (NSSI) by youth in contact with the juvenile justice system. Opportunities for detection and prevention start at early points of contact (e.g., police interaction, the intake interview) and continue through many juvenile justice settings (e.g., pre-trial detention, juvenile or family court activities, court disposition, placement and on-going care in either residential or multiple community settings.) This FOA invites intervention strategies that are designed to be delivered in typical service settings using typically available personnel and resources, to enhance the implementation of interventions that prove effective, enhance their future uptake in diverse settings, and thereby reduce risk of suicide and self-harm in this population. This FOA is published in parallel to a companion R34 FOA (PAR-xx-xxx) supporting pilot studies in preparation for the larger-scale studies described here.

Notice of Correction for PAR-18-464 Clinical and Translational Science Award (U54 Clinical Trial Optional)

Thu, 2017-12-07 10:20
Notice NOT-TR-18-012 from the NIH Guide for Grants and Contracts

Notice of Correction to Funding Opportunity Description for RFA-HL-16-025 "NHLBI Emerging Investigator Award (EIA) (R35)"

Thu, 2017-12-07 10:08
Notice NOT-HL-17-569 from the NIH Guide for Grants and Contracts

NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01) - Clinical Trial Required

Thu, 2017-12-07 09:59
Funding Opportunity PAR-18-486 from the NIH Guide for Grants and Contracts. The purpose of the NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01) is to diversify the pool of independent neuroscience research investigators by providing junior faculty with research cost support, protected research time and career stage appropriate professional development mentorship in neuroscience research. Individuals from backgrounds underrepresented in biomedical research are eligible for support under this award if they have doctoral research degrees (Ph.D. or equivalent) and are in the first 3 years of a faculty tenure track or equivalent position at the time of award.

NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01) - Clinical Trial Not Allowed

Thu, 2017-12-07 09:59
Funding Opportunity PAR-18-490 from the NIH Guide for Grants and Contracts. The purpose of the NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01) is to diversify the pool of independent neuroscience research investigators by providing junior faculty with research cost support, protected research time and career stage appropriate professional development mentorship in neuroscience research. Individuals from backgrounds underrepresented in biomedical research are eligible for support under this award if they have doctoral research degrees (Ph.D. or equivalent) and are in the first 3 years of a faculty tenure track or equivalent position at the time of award.

Notice of Correction to Funding Opportunity Description for RFA-HL-16-024 "NHLBI Outstanding Investigator Award (OIA) (R35)"

Thu, 2017-12-07 03:25
Notice NOT-HL-17-568 from the NIH Guide for Grants and Contracts

Notice of Interest to Highlight NIDA High-Priority Workforce Development Needs in the Chemistry of Addiction

Thu, 2017-12-07 01:13
Notice NOT-DA-17-063 from the NIH Guide for Grants and Contracts

Findings of Research Misconduct

Thu, 2017-12-07 01:09
Notice NOT-OD-18-113 from the NIH Guide for Grants and Contracts

Pages